Zachary Grinspan, MD, MS
Dr. Grinspan is Associate Professor, Interim Chief of Child Neurology, and Director of Pediatric Epilepsy at New York Presbyterian Hospital-Weill Cornell Medicine in New York City. He graduated from Yale University in 1996, taught high school through the Teach for America Program, then attended and graduated medical school from the Albert Einstein College of Medicine in 2004. He completed pediatrics training at the Mass General Hospital for Children, neurology training at Columbia University Medical Center, and epilepsy training at Montefiore Medical Center, then joined Weill Cornell Medicine in 2011. At Cornell, he obtained a master’s degree in biostatistics and completed a postdoctoral fellowship in quality of care and medical informatics. His published research (100+ peer reviewed articles) includes collaborations with experts across multiple disciplines (epilepsy, emergency medicine, critical care, health services research, informatics, biostatistics, machine learning, economics). Dr. Grinspan is the primary investigator for the Pediatric Epilepsy Learning Healthcare System (PELHS), a 20+ center federally funded collaboration which aims to reduce seizures and their consequences for children with epilepsy through cycles of health data collection and analysis. The vision of PELHS is that all children with epilepsy receive timely and optimal care according to standards that are continuously improved.
Financial relationships
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Amgen (formally Horizon Therapeutics)Date added:08/19/2024Date updated:09/26/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Capsida BiotherapeuticsDate added:09/26/2024Date updated:09/26/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Encoded TherapeuticsDate added:09/26/2024Date updated:09/26/2024
-
Attribution:SelfType of financial relationship:Professional ServicesIneligible company:Mahzi TherapeuticsDate added:09/26/2024Date updated:09/26/2024
-
Type of financial relationship:Professional ServicesIneligible company:Neurvati TherapeuticsDate added:09/26/2024Date updated:09/26/2024